Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 3
1984 1
1985 1
1986 1
1987 5
1988 3
1989 4
1990 8
1991 1
1992 3
1993 5
1994 3
1995 4
1996 6
1997 6
1998 7
1999 8
2000 4
2001 11
2002 9
2003 11
2004 10
2005 13
2006 10
2007 14
2008 14
2009 11
2010 7
2011 16
2012 7
2013 12
2014 15
2015 12
2016 9
2017 7
2018 7
2019 3
2020 4
2021 5
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

274 results

Results by year

Filters applied: . Clear all
Page 1
Quality assurance for drug prescribing.
Soumerai SB, McLaughlin TJ, Avorn J. Soumerai SB, et al. Qual Assur Health Care. 1990;2(1):37-58. doi: 10.1093/intqhc/2.1.37. Qual Assur Health Care. 1990. PMID: 2103870 Review.
Affordability of Medical Care Among Medicare Enrollees.
Madden JM, Bayapureddy S, Briesacher BA, Zhang F, Ross-Degnan D, Soumerai SB, Gurwitz JH, Galbraith AA. Madden JM, et al. Among authors: soumerai sb. JAMA Health Forum. 2021 Dec 10;2(12):e214104. doi: 10.1001/jamahealthforum.2021.4104. eCollection 2021 Dec. JAMA Health Forum. 2021. PMID: 35977305 Free PMC article.
Response to the letter by Mol.
Briesacher BA, Soumerai SB, Zhang F, Toh S, Andrade SE, Wagner JL, Shoaibi A, Gurwitz JH. Briesacher BA, et al. Among authors: soumerai sb. Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):106. doi: 10.1002/pds.3519. Pharmacoepidemiol Drug Saf. 2014. PMID: 24395548 No abstract available.
A critical review of methods to evaluate the impact of FDA regulatory actions.
Briesacher BA, Soumerai SB, Zhang F, Toh S, Andrade SE, Wagner JL, Shoaibi A, Gurwitz JH. Briesacher BA, et al. Among authors: soumerai sb. Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):986-94. doi: 10.1002/pds.3480. Epub 2013 Jul 12. Pharmacoepidemiol Drug Saf. 2013. PMID: 23847020 Free PMC article. Review.
274 results